15-hydroxy-5,8,11,13,17-eicosapentaenoic acid has been researched along with Hypertension, Pulmonary in 1 studies
15-hydroxy-5,8,11,13,17-eicosapentaenoic acid: structure given in first source; RN given refers to parent cpd
Hypertension, Pulmonary: Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wei, L | 1 |
| Yu, X | 1 |
| Shi, H | 1 |
| Zhang, B | 1 |
| Lian, M | 1 |
| Li, J | 1 |
| Shen, T | 1 |
| Xing, Y | 1 |
| Zhu, D | 1 |
1 other study available for 15-hydroxy-5,8,11,13,17-eicosapentaenoic acid and Hypertension, Pulmonary
| Article | Year |
|---|---|
15-PGDH/15-KETE plays a role in hypoxia-induced pulmonary vascular remodeling through ERK1/2-dependent PAR-2 pathway.
Topics: Animals; Arachidonic Acids; Cell Cycle; Cell Cycle Proteins; Cell Hypoxia; Cell Proliferation; Cells | 2014 |